Aspirin resistance in atherosclerosis

Area of Science:

• Cardiovascular Medicine
• Pharmacology
• Genetics

Background:

• Aspirin resistance is clinically defined as the failure of aspirin therapy to prevent thrombotic events.
• Laboratory definitions focus on aspirin's inability to achieve adequate platelet inhibition.
• The failure of aspirin to prevent events despite cyclooxygenase-1 inhibition suggests other factors are involved.

Purpose of the Study:

• To explore the underlying mechanisms of aspirin resistance.
• To investigate the role of enhanced basal platelet function and hereditary factors in aspirin resistance.
• To understand the limitations of aspirin therapy in managing thrombotic complications in atherosclerosis.

Main Methods:

• Review of clinical and laboratory definitions of aspirin resistance.
• Analysis of emerging evidence on platelet activity and hereditary components.
• Consideration of the multifactorial nature of cardiovascular disease.

Main Results:

• Aspirin resistance may reflect an individual's enhanced basal platelet function.
• A hereditary component is suggested as a factor in aspirin resistance.
• Atherosclerosis involves multiple factors, complicating single-drug therapies.

Conclusions:

• Aspirin resistance is a complex phenomenon potentially linked to individual genetic predispositions.
• Enhanced basal platelet activity and hereditary factors contribute to aspirin resistance.
• Single-agent therapies like aspirin may be insufficient for comprehensive prevention of thrombotic complications in atherosclerosis.